Knowledge management and discovery software developer Collexis Holdings, Inc., US, announced that Johns Hopkins University has become the latest institution to sign onto Collexis Expertise Profiling System for their entire medical community. The agreement represents an expansion of Collexis' 18 month relationship with Johns Hopkins University, and will include all researchers from the School of Medicine, School of Nursing and School of Public Health.
The Collexis system creates updated profiles of University researchers based on their publications, grants and/or other associated work. The Collexis Platform was previously adopted across the National Institute of Health and is expected to be fully integrated with BiomedExperts.com, the first pre-populated, scientific social network for life science researchers. This agreement with Johns Hopkins will create a Clinical Translational Research Platform for the University's more than 2,800 medical researchers to connect and share their expertise via an updating web interface. Under the new deal, Collexis will use its proprietary Fingerprinting process to search text for ideas and concepts rather than keywords and create Collexis Fingerprints or conceptual maps.
The Expert Profiles will be generated using the Collexis fingerprints of the researchers' publications from a variety of sources. Profiles are then available to be viewed and searched by all researchers. The expert profiling solution for Johns Hopkins is based on Collexis biomedical highly disambiguated expert database, which is the basis for the life science social networking site www.biomedexperts.com with 1.5 million expert profiles from researchers and 20 million connections between scientists around the globe.
In addition to Johns Hopkins, Collexis is bringing its innovative technology to other medical research organisations and universities world-wide. These include the Mayo Clinic Libraries; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and US Department of Defense.
